URGN · UroGen Pharma Ltd.
Market Cap
$2.13B
Shares
48.88M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-05 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-05-26 | TD Cowen 7th Annual Oncology Innovation Summit | Webcast |
| 2026-05-19 | HC Wainwright 4th Annual BioConnect Investor Conference | Conference |
| 2026-05-17 | Right Patient, Right Treatment: Real-World Insights on ZUSDURI™ (mitomycin) for Intravesical Solution | Webcast |
| 2026-05-13 | Bank of America Health Care Conference 2026 | Conference |
| 2026-05-06 | UroGen Pharma Q1 2026 Earnings Call | Earnings call |
| 2026-03-03 | TD Cowen 46th Annual Health Care Conference | Conference |
| 2026-03-02 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-02-12 | Guggenheim Emerging Outlook: Biotech Summit 2026 | Webcast |
| 2025-12-02 | Piper Sandler 37th Annual Healthcare Conference | Conference |
| 2025-11-11 | Guggenheim Securities Innovation Conference | Conference |
| 2024-06-13 | ZUSDURI 12-Month Durability of Response Data Event | Webcast |
Source: https://investors.urogen.com/
Key facts
CIK
1668243
CUSIP
M96088105
13F (30d)
166 filings
166 filers
Visit website
Investor relations